Author:
Faksova K.,Walsh D.,Jiang Y.,Griffin J.,Phillips A.,Gentile A.,Kwong J.C.,Macartney K.,Naus M.,Grange Z.,Escolano S.,Sepulveda G.,Shetty A.,Pillsbury A.,Sullivan C.,Naveed Z.,Janjua N.Z.,Giglio N.,Perälä J.,Nasreen S.,Gidding H.,Hovi P.,Vo T.,Cui F.,Deng L.,Cullen L.,Artama M.,Lu H.,Clothier H.J.,Batty K.,Paynter J.,Petousis-Harris H.,Buttery J.,Black S.,Hviid A.
Funder
Centers for Disease Control and Prevention
Reference46 articles.
1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (accessed October 13, 2023).
2. Our World in Data. Coronavirus (COVID-19) Vaccinations - Our World in Data 2023. https://ourworldindata.org/covid-vaccinations (accessed October 13, 2023).
3. Safety Platform for Emerging Vaccines S. D2.3 Priority list of adverse events of special interest: COVID-19. Brighton Collaboration; 2020. Available from: https://zenodo.org/records/6656179#.Y-0yxuyZOnN.
4. Observed-over-Expected analysis as additional method for pharmacovigilance signal detection in large-scaled spontaneous adverse event reporting;van der Boom;Pharmacoepidemiol Drug Saf,2023
5. Pharmacoepidemiological considerations in observed-to-expected analyses for vaccines;Mahaux;Pharmacoepidemiol Drug Saf,2016
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献